Clinical Trials Directory

Trials / Unknown

UnknownNCT03970421

Severity Factors and Needed Observation Time at ED of Patients Wih Head Injury

Demographic and Clinical Data Associated to Head Injury Severity on Adults Patients (Older Than 16yo), and Follow up for 90 Days to Check the Development of Associated Complications, Deciding the Optimal Observation Lapse at ED

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Hospital El Escorial · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

We know precisely which patients and when they should have an imaging test to evaluate a Head Injury (HI). But in those patients on anticoagulant and / or antiaggregant treatment we do not know the exact incidence of early and late hemorrhagic lesions, and there is no specific recommendation on how long they should remain under observation in the emergency department if no initial lesions are evident. Our goal is to try to answer these two questions.

Detailed description

MATERIAL: Prospective study of patients treated of HI in the Emergency Department (ED) and to whom an image test is performed (cranial CT scan). Collection of demographic, clinical, analytical, image tests, and observation time in the emergency department (from admission to medical discharge) METHODS: Separation of subjects included in the study in 4 cohorts: patients without anticoagulant and / or antiaggregant treatment; patients with antiplatelet therapy (ASA and / or clopidogrel); patients with anticoagulant treatment with acenocoumarol and INR \<2; and patients on anticoagulant therapy with acenocoumarol and INR\> = 2 or patients on treatment with direct thrombin inhibitors (dabigatran), or inhibitors of factor Xa (rivaroxaban, apixaban, edoxaban) or patients on treatment with low molecular weight heparins (LMWH) ) Follow-up through analysis of clinical history and telephone interview at 2, 7, 15, 30, 60 and 90 days. Statistical analysis of the results.

Conditions

Interventions

TypeNameDescription
OTHERObservationCheck clinical status at different time intervals during 3 months

Timeline

Start date
2019-06-01
Primary completion
2019-12-01
Completion
2020-03-01
First posted
2019-05-31
Last updated
2019-05-31

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03970421. Inclusion in this directory is not an endorsement.